Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check2 days agoChange DetectedRevision now shows v3.0.2 (replacing v3.0.1) and the 'Back to Top' link has been removed. This is a minor maintenance update with no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has added significant information regarding a facility and its publications related to acute myeloid leukemia, while also removing several specific terms and details about locations and types of leukemia.SummaryDifference5%
- Check23 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.6%
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.6%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.